deltatrials
Completed NA INTERVENTIONAL 3-arm NCT04253808

Feasibility of a Carbohydrate-restricted, High-fat Diet on Head and Neck Squamous Cell Carcinoma Outcomes (CRHF)

Feasibility of a Carbohydrate-restricted, High-fat Diet to Improve Outcomes in Head and Neck Squamous Cell Carcinoma: A Pilot Randomized Controlled Feeding Trial

Sponsor: Augusta Victoria Hospital, East Jerusalem

Updated 6 times since 2020 Last updated: Oct 28, 2021 Started: Feb 3, 2020 Primary completion: Aug 10, 2021 Completion: Aug 10, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Head and Neck Squamous Cell Carcinoma and is currently completed. Augusta Victoria Hospital, East Jerusalem leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotRecruiting~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotRecruiting~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Dec 2021 — Jul 2024 [monthly]

    Completed NA

    Status: RecruitingCompleted

  5. Jan 2021 — Dec 2021 [monthly]

    Recruiting NA

Show 1 earlier version
  1. Mar 2020 — Jan 2021 [monthly]

    Recruiting NA

    First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Augusta Victoria Hospital, East Jerusalem
  • University of Illinois at Urbana-Champaign
Data source: University of Illinois at Urbana-Champaign

For direct contact, visit the study record on ClinicalTrials.gov .